Les principaux facteurs incluent l'âge avancé, le sexe féminin et des antécédents familiaux.
Facteurs de risqueÂge avancéAntécédents familiaux
#2
Le tabagisme est-il un facteur de risque ?
Oui, le tabagisme est associé à un risque accru d'artérite temporale.
TabagismeFacteurs de risqueArtérite
#3
Les maladies auto-immunes augmentent-elles le risque ?
Oui, certaines maladies auto-immunes peuvent augmenter le risque d'artérite temporale.
Maladies auto-immunesFacteurs de risqueArtérite
#4
L'inflammation chronique est-elle un facteur de risque ?
Oui, l'inflammation chronique dans le corps peut contribuer au développement de l'artérite temporale.
Inflammation chroniqueFacteurs de risqueArtérite
#5
Les antécédents de migraines influencent-ils le risque ?
Des antécédents de migraines peuvent être associés à un risque accru d'artérite temporale.
MigrainesFacteurs de risqueArtérite
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Artères temporales : Questions médicales les plus fréquentes",
"headline": "Artères temporales : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Artères temporales : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-08-05",
"dateModified": "2025-02-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Artères temporales"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Artères cérébrales",
"url": "https://questionsmedicales.fr/mesh/D002536",
"about": {
"@type": "MedicalCondition",
"name": "Artères cérébrales",
"code": {
"@type": "MedicalCode",
"code": "D002536",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A07.015.114.228"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Artères temporales",
"alternateName": "Temporal Arteries",
"code": {
"@type": "MedicalCode",
"code": "D013699",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Tugba Morali Guler",
"url": "https://questionsmedicales.fr/author/Tugba%20Morali%20Guler",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurosurgery, Karabuk University, School of Medicine, Karabuk."
}
},
{
"@type": "Person",
"name": "Yahya Efe Guner",
"url": "https://questionsmedicales.fr/author/Yahya%20Efe%20Guner",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurosurgery, Yuksek Ihtisas University, School of Medicine."
}
},
{
"@type": "Person",
"name": "Ali Can Korkmaz",
"url": "https://questionsmedicales.fr/author/Ali%20Can%20Korkmaz",
"affiliation": {
"@type": "Organization",
"name": "Department of Anatomy."
}
},
{
"@type": "Person",
"name": "Yigit Gungor",
"url": "https://questionsmedicales.fr/author/Yigit%20Gungor",
"affiliation": {
"@type": "Organization",
"name": "Department of Anatomy."
}
},
{
"@type": "Person",
"name": "Yagiz Emre Sayaci",
"url": "https://questionsmedicales.fr/author/Yagiz%20Emre%20Sayaci",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurosurgery."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Strengthening Australia's Chemical Regulation.",
"datePublished": "2022-05-30",
"url": "https://questionsmedicales.fr/article/35682256",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph19116673"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Wellbeing Index for South Australia.",
"datePublished": "2023-04-25",
"url": "https://questionsmedicales.fr/article/37039339",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/hpja.731"
}
},
{
"@type": "ScholarlyArticle",
"name": "Tapentadol exposures and poisonings in Australia.",
"datePublished": "2022-06-07",
"url": "https://questionsmedicales.fr/article/35670823",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/15563650.2022.2074857"
}
},
{
"@type": "ScholarlyArticle",
"name": "Endometriosis research priorities in Australia.",
"datePublished": "2023-05-24",
"url": "https://questionsmedicales.fr/article/37226362",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/ajo.13699"
}
},
{
"@type": "ScholarlyArticle",
"name": "Analysis of surgical mortality in rural South Australia: a review of four major rural hospital in South Australia.",
"datePublished": "2022-06-08",
"url": "https://questionsmedicales.fr/article/35674399",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/ans.17833"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Système cardiovasculaire",
"item": "https://questionsmedicales.fr/mesh/D002319"
},
{
"@type": "ListItem",
"position": 3,
"name": "Vaisseaux sanguins",
"item": "https://questionsmedicales.fr/mesh/D001808"
},
{
"@type": "ListItem",
"position": 4,
"name": "Artères",
"item": "https://questionsmedicales.fr/mesh/D001158"
},
{
"@type": "ListItem",
"position": 5,
"name": "Artères cérébrales",
"item": "https://questionsmedicales.fr/mesh/D002536"
},
{
"@type": "ListItem",
"position": 6,
"name": "Artères temporales",
"item": "https://questionsmedicales.fr/mesh/D013699"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Artères temporales - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Artères temporales",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-04-29",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Artères temporales",
"description": "Comment diagnostiquer une artérite temporale ?\nQuels tests sont utilisés pour évaluer les artères temporales ?\nQuels signes indiquent une inflammation des artères temporales ?\nQuel rôle joue la vitesse de sédimentation dans le diagnostic ?\nQuand faut-il suspecter une artérite temporale ?",
"url": "https://questionsmedicales.fr/mesh/D013699?mesh_terms=Australia#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Artères temporales",
"description": "Quels sont les symptômes courants de l'artérite temporale ?\nComment se manifeste la douleur liée aux artères temporales ?\nLes troubles de la vision sont-ils fréquents ?\nY a-t-il des symptômes systémiques associés ?\nComment la douleur à la mâchoire est-elle liée à l'artérite temporale ?",
"url": "https://questionsmedicales.fr/mesh/D013699?mesh_terms=Australia#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Artères temporales",
"description": "Peut-on prévenir l'artérite temporale ?\nQuels modes de vie peuvent aider à réduire les risques ?\nLes facteurs de risque peuvent-ils être modifiés ?\nLe suivi médical est-il important ?\nLes vaccinations peuvent-elles aider ?",
"url": "https://questionsmedicales.fr/mesh/D013699?mesh_terms=Australia#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Artères temporales",
"description": "Quel est le traitement principal de l'artérite temporale ?\nCombien de temps dure le traitement par corticostéroïdes ?\nDes médicaments supplémentaires sont-ils nécessaires ?\nComment surveiller l'efficacité du traitement ?\nY a-t-il des effets secondaires des corticostéroïdes ?",
"url": "https://questionsmedicales.fr/mesh/D013699?mesh_terms=Australia#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Artères temporales",
"description": "Quelles sont les complications possibles de l'artérite temporale ?\nComment la perte de vision se produit-elle ?\nLes AVC sont-ils fréquents avec l'artérite temporale ?\nComment prévenir les complications ?\nY a-t-il des complications à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D013699?mesh_terms=Australia#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Artères temporales",
"description": "Quels sont les principaux facteurs de risque ?\nLe tabagisme est-il un facteur de risque ?\nLes maladies auto-immunes augmentent-elles le risque ?\nL'inflammation chronique est-elle un facteur de risque ?\nLes antécédents de migraines influencent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D013699?mesh_terms=Australia#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une artérite temporale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par une évaluation clinique et une biopsie de l'artère temporale."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les artères temporales ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'échographie Doppler et l'IRM peuvent être utilisés pour évaluer les artères temporales."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une inflammation des artères temporales ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs à la tête, une sensibilité du cuir chevelu et des troubles visuels peuvent indiquer une inflammation."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la vitesse de sédimentation dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une vitesse de sédimentation élevée peut indiquer une inflammation associée à l'artérite temporale."
}
},
{
"@type": "Question",
"name": "Quand faut-il suspecter une artérite temporale ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il faut suspecter une artérite temporale en cas de céphalées persistantes chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de l'artérite temporale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, une douleur à la mâchoire et des troubles visuels."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la douleur liée aux artères temporales ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La douleur est souvent localisée sur le côté de la tête et peut être intense et pulsatile."
}
},
{
"@type": "Question",
"name": "Les troubles de la vision sont-ils fréquents ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la vision, comme la perte de vision temporaire, peuvent survenir."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fièvre, la fatigue et la perte de poids peuvent également être présents."
}
},
{
"@type": "Question",
"name": "Comment la douleur à la mâchoire est-elle liée à l'artérite temporale ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La douleur à la mâchoire, surtout lors de la mastication, peut indiquer une atteinte des artères temporales."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir l'artérite temporale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi médical régulier est conseillé."
}
},
{
"@type": "Question",
"name": "Quels modes de vie peuvent aider à réduire les risques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter un mode de vie sain, avec une alimentation équilibrée et de l'exercice, peut aider."
}
},
{
"@type": "Question",
"name": "Les facteurs de risque peuvent-ils être modifiés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains facteurs comme le tabagisme et l'hypertension peuvent être modifiés pour réduire les risques."
}
},
{
"@type": "Question",
"name": "Le suivi médical est-il important ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi médical régulier permet de détecter précocement les signes d'inflammation."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations contre certaines infections peuvent indirectement réduire les risques d'inflammation."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal de l'artérite temporale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est l'administration de corticostéroïdes pour réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Combien de temps dure le traitement par corticostéroïdes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut durer plusieurs mois, avec un suivi régulier pour ajuster la dose."
}
},
{
"@type": "Question",
"name": "Des médicaments supplémentaires sont-ils nécessaires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments immunosuppresseurs peuvent être ajoutés si les corticostéroïdes ne suffisent pas."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'efficacité du traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La surveillance se fait par des examens cliniques et des tests sanguins réguliers."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires des corticostéroïdes ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme la prise de poids, l'hypertension et l'ostéoporose peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de l'artérite temporale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la perte de vision permanente et les accidents vasculaires cérébraux."
}
},
{
"@type": "Question",
"name": "Comment la perte de vision se produit-elle ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La perte de vision peut survenir en raison d'une ischémie des artères ophtalmiques."
}
},
{
"@type": "Question",
"name": "Les AVC sont-ils fréquents avec l'artérite temporale ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les AVC peuvent survenir en raison de l'inflammation des vaisseaux sanguins."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement précoce et un suivi régulier sont essentiels pour prévenir les complications."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications à long terme peuvent inclure des douleurs chroniques et des troubles cognitifs."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent l'âge avancé, le sexe féminin et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un risque accru d'artérite temporale."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent augmenter le risque d'artérite temporale."
}
},
{
"@type": "Question",
"name": "L'inflammation chronique est-elle un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'inflammation chronique dans le corps peut contribuer au développement de l'artérite temporale."
}
},
{
"@type": "Question",
"name": "Les antécédents de migraines influencent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents de migraines peuvent être associés à un risque accru d'artérite temporale."
}
}
]
}
]
}
Department of Plastic and Reconstructive Surgery, Guangdong Second Provincial General Hospital, 466 Middle Xin Gang Road, Guangzhou City, 510317, Guangdong Province, People's Republic of China.
Department of Plastic and Reconstructive Surgery, Guangdong Second Provincial General Hospital, 466 Middle Xin Gang Road, Guangzhou City, 510317, Guangdong Province, People's Republic of China.
Department of Plastic and Reconstructive Surgery, Guangdong Second Provincial General Hospital, 466 Middle Xin Gang Road, Guangzhou City, 510317, Guangdong Province, People's Republic of China.
Department of Plastic and Reconstructive Surgery, Guangdong Second Provincial General Hospital, 466 Middle Xin Gang Road, Guangzhou City, 510317, Guangdong Province, People's Republic of China.
Department of Plastic and Reconstructive Surgery, Guangdong Second Provincial General Hospital, 466 Middle Xin Gang Road, Guangzhou City, 510317, Guangdong Province, People's Republic of China. luoshk@gd2h.org.cn.
Division in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul, South Korea.
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
Department of Neurological Surgery, University of California San Francisco, 505 Parnassus Ave, San Francisco, CA, 94143, USA. william.rutledge@ucsf.edu.
Division of Vascular Medicine, Medicial Clinic and Policlinic IV, Hospital of the Ludwig Maximilians University, Munich, Germany michael.czihal@med.uni-muenchen.de.
Humans are exposed to a myriad of chemicals every day, some of which have been established to have deleterious effects on human health. Regulatory frameworks play a vital role in safeguarding human he...
Wellbeing SA, an independent South Australian government agency, developed a Wellbeing Index for South Australia across a 12-month period in 2021-2022 to enable the measurement of wellbeing outcomes f...
The development of the Index was a methodical process based on two key emphases-evidence-based action and working in partnership. The steps included a scoping of existing wellbeing measurement framewo...
A Wellbeing Index for South Australia was launched in June 2022 on the Wellbeing SA website. It is structured against domains of physical, mental, social/community, Aboriginal cultural wellbeing and t...
The Index communicates the importance and the breadth of wellbeing outcomes addressed by the various health promotion and policy actors in South Australia and provides a sound basis for monitoring the...
Tapentadol is an atypical opioid with mu-receptor affinity and noradrenaline reuptake inhibition approved for use in Australia in 2011. However, data on tapentadol poisoning are scarce....
To investigate tapentadol poisonings and related deaths in Australia....
We performed a retrospective review of tapentadol poisonings from New South Wales Poisons Information Centre (NSWPIC) and three toxicology units in Australia. The National Coronial Information System ...
Between 2016 and 2020, 220 tapentadol calls were made to NSWPIC, with a 4.5-fold increase in tapentadol exposure calls. The median dose ingested was 575 mg (IQR: 300-1163 mg). Most overdoses included ...
There are increasing tapentadol poisonings and deaths reported to the NSWPIC, three toxicology units, and NCIS in Australia. Most tapentadol poisonings were taken with benzodiazepines and/or other opi...
In Australia, endometriosis affects one in nine women and those assigned female at birth. Although endometriosis is more common than conditions such as diabetes, research funding for endometriosis res...
One-third of Australia's population reside in rural and remote areas. This audit aims to describe all-causes of mortality in rural general surgical patients, and identify areas of improvement....
This is a retrospective multi-centre study involving four South Australian hospitals (Mt Gambier, Whyalla, Port Augusta, and Port Lincoln). All general surgical inpatients admitted from June 2014 to S...
A total of 80 mortalities were recorded out of 26 996 admissions. The overall mortality rate of 0.3% was the same as the 2020 Victorian state-wide Audit of Surgical Mortality. No mortality was seconda...
Rural general surgical mortalities occur in older, comorbid patients. Rural surgeons should be equipped to manage basic subspeciality conditions. To further reduce mortalities, clear protocols to prev...
Although several interventions have been shown to be effective in preventing suicide at high-risk locations, the potential for these interventions to be deployed is limited by a lack of knowledge abou...
To identify high-risk suicide locations in Australia and the factors associated with choosing these locations....
This case-control study included data on individuals who died by suicide in Australia between January 2001 and December 2017, obtained from the National Coronial Information System. Data analysis was ...
Sociodemographic, residential, incident time, and incident location variables....
The scan statistic was used to detect spatial clusters of suicides in public locations. Suicide locations within significant clusters with at least 0.5 suicides per year were defined as high-risk loca...
Over the study period, 10 701 suicides took place in public places. The individuals who died of suicide in public places included 8602 (80.4%) male individuals, and most were aged 25 to 49 years (5825...
This case-control study found 17 high-risk suicide locations in Australia and the factors associated with the choice of these locations. Actions should be taken to prevent suicide at these locations w...
This study aimed to ascertain frequency rates and predictors of six problematic online behaviors (POBs) in an Australian sample. Participants (N = 1626) completed instruments measuring problematic onl...
Background The burden of cardiovascular disease is increasing, with many people treated for multiple cardiovascular conditions. We examined persistence and adherence to medicines for cardiovascular di...
As climate change produces more extreme weather, it is increasingly important to understand the impacts of these changes on social behaviour. The relationship between weather and crime has been studie...
Person-centred care (PCC) and shared decision-making (SDM) are part of national clinical standards for an increasing number of areas of health care delivery. In addition to existing standards for accr...